Award type :
Product Development Award
Product Development Award
Product type :
Diagnostics
Diagnostics
Award year :
2020
2020
Project start date :
07 / 03 / 2020
07 / 03 / 2020
Project end date :
09 / 17 / 2021
09 / 17 / 2021
Project duration (months) :
12
12
Development stage :
Early Validation
Early Validation
Target disease :
Malaria
Malaria
Region served :
World
World
Recipient organization / Country of funding recipient organization :
Solgent / Republic of Korea
Solgent / Republic of Korea
Collaborator(s) / Country :
-
-
Funding amount(KRW) :
330,000,000
330,000,000
This project aims to develop quantitative, low-cost glucose-6-phosphate dehydrogenase (G6PD) point-of-care (POC) test using a proprietary blue fluorescent protein (mBFP) by Solgent that meets the needs of a low-cost G6PD test before malaria treatment. Validation of the test may allow for the expansion of the mBFP technology to other diseases.